Kim, C. et al. found that the low-level expression of estrogen receptor 1 (ESR1) in breast cancer tissue samples is correlated with endocrine therapy resistance in estrogen receptor (ER)-positive primary breast cancer and is associated with the treatment outcome [49]. Here, ESR1 is linked to breast carcinoma.